Home / Generics

Generics

News

FDA approves rare disease deflazacort at exorbitant price posted 17/03/2017

Deflazacort is a steroid treatment that has long been approved in many countries outside the US. In February 2016, the US Foo...

Generic lung cancer treatment now available in China posted 10/03/2017

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the market in China. This generic drug is being...

US approves generic of narcolepsy drug Xyrem posted 24/02/2017

The US Food and Drug Administration (FDA) has approved the first generic version of Xyrem (sodium oxybate) – the only drug ap...

Endo launches generic version of Zetia posted 31/01/2017

Ireland-based Endo International plc has announced that its operating company Par Pharmaceutical will ship the first generic...

Natco Pharma and Alvogen launch first US Tamiflu generic posted 20/01/2017

Natco Pharma (Natco) and their marketing partner Alvogen have launched the first generic equivalent of Roche’s flu treatment...

 

Research

Potency of generics of piperacillin/tazobactam posted 24/03/2017

In an era of increasing bacterial resistance, the potency of antibiotics is critical. Researchers from the Tata Medical Centr...

Delaying generics using citizen petitions posted 17/03/2017

A study of citizen petitions submitted to the US Food and Drug Administration (FDA) over the last 12 years finds that such pe...

Promoting and regulating generics in Brazil posted 17/03/2017

Generic drug substitution constitutes a core instrument of countries’ strategies to reduce the price of drugs and expand acce...

Rising costs of cancer treatments not matched by clinical efficacy posted 17/03/2017

The high prices of new cancer treatments are a major barrier to access in low-income countries and placing growing pressure o...

Generics and brand-name drugs compared posted 17/03/2017

What differentiates generics from brand-name medications? That is a question that Andrea Bakker from the Faculty of Medicine...

 

General

Malaysian Government approves new generics facility posted 09/03/2017

Bangladesh-based generics firm Beximco Pharmaceuticals (Beximco) has made a deal with Malaysia’s BioCare Manufacturing (BioCa...

Novo Nordisk becomes second pharma company to cap price hikes posted 01/03/2017

Danish pharmaceutical company Novo Nordisk has pledged to limit the price rises of their drugs to single digit increases each...

Generics regulators outline priorities to 2020 posted 31/01/2017

The International Generic Drug Regulatory Programme (IGDRP) announced on 21 December 2016 that it had released its ‘Road...

Generics applications under review by EMA – December 2016 posted 20/01/2017

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

UK competition authority accuses Actavis of overcharging NHS posted 13/01/2017

The UK’s Competition and Markets Authority (CMA) has accused Actavis of breaching competition law by increasing the price of...